We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+20.33%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$600M
AUM Growth
+$79.5M
Cap. Flow
+$21.8M
Cap. Flow %
3.64%
Top 10 Hldgs %
21.67%
Holding
133
New
15
Increased
59
Reduced
31
Closed
12

Top Buys

Rank Stock Value
1
MMSI icon
Merit Medical Systems
MMSI
+$6.18M
2
PRVA icon
Privia Health
PRVA
+$5.98M
3
CNMD icon
CONMED
CNMD
+$5.55M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$5.01M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$4.97M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$12.1M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$11.6M
3
IMGN
Immunogen Inc
IMGN
+$6.67M
4
BLU
BELLUS Health Inc.
BLU
+$5.53M
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 95.97%
2 Industrials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
76
Danaher
DHR
$138B
$2.63M 0.44%
12,380
-733
-6% -$155K
SILK
77
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$2.62M 0.44%
80,500
-15,089
-16% -$551K
GILD icon
78
Gilead Sciences
GILD
$163B
$2.52M 0.42%
32,682
+6,982
+27% +$557K
ANNX icon
79
Annexon
ANNX
$863M
$2.37M 0.4%
674,629
+347,823
+106% +$1.52M
REGN icon
80
Regeneron Pharmaceuticals
REGN
$76B
$2.3M 0.38%
3,196
+406
+15% +$313K
RLYB icon
81
Rallybio
RLYB
$85.3M
$2.13M 0.35%
46,995
-21,997
-32% -$1.08M
EQRX
82
DELISTED
EQRx, Inc. Common Stock
EQRX
$2.11M 0.35%
+1,135,967
New +$2.03M
PMVP icon
83
PMV Pharmaceuticals
PMVP
$60.3M
$2.08M 0.35%
332,250
+81,781
+33% +$429K
BEAM icon
84
Beam Therapeutics
BEAM
$2.73B
$2.03M 0.34%
63,500
– –
EFTR
85
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.98M 0.33%
95,306
– –
GBIO
86
DELISTED
Generation Bio
GBIO
$1.96M 0.33%
35,674
-2,833
-7% -$130K
ITOS
87
DELISTED
iTeos Therapeutics
ITOS
$1.94M 0.32%
146,576
+58,203
+66% +$830K
ALLK
88
DELISTED
Allakos
ALLK
$1.89M 0.32%
+434,310
New +$1.95M
MGNX icon
89
MacroGenics
MGNX
$240M
$1.89M 0.31%
+352,497
New +$2.17M
AVIR icon
90
Atea Pharmaceuticals
AVIR
$379M
$1.88M 0.31%
501,537
+120,687
+32% +$452K
STRO icon
91
Sutro Biopharma
STRO
$411M
$1.86M 0.31%
+40,065
New +$1.99M
SRRK icon
92
Scholar Rock
SRRK
$5.87B
$1.85M 0.31%
245,735
+111,166
+83% +$839K
TELA icon
93
TELA Bio
TELA
$31.8M
$1.81M 0.3%
+178,372
New +$1.82M
BCAB icon
94
BioAtla
BCAB
$5.61M
$1.67M 0.28%
11,130
+270
+2% +$46.4K
HUM icon
95
Humana
HUM
$44B
$1.6M 0.27%
3,575
– –
MRNA icon
96
Moderna
MRNA
$23B
$1.56M 0.26%
12,828
-4,890
-28% -$652K
SGEN
97
DELISTED
Seagen Inc. Common Stock
SGEN
$1.54M 0.26%
8,015
-11,335
-59% -$2.25M
AZN icon
98
AstraZeneca
AZN
$266B
$1.52M 0.25%
10,613
+608
+6% +$89.5K
XBI icon
99
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.5M 0.25%
18,032
-25,321
-58% -$2.12M
ONC
100
BeOne Medicines Ltd
ONC
$33.4B
$1.03M 0.17%
5,800
+290
+5% +$66.8K
2 3
4
5 6

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sectoral Asset Management held 133 positions worth $600M, up 15% from $520M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Sectoral Asset Management deployed $21.8M of net new capital in Q2 2023, opening 15 new positions and adding to 59 existing holdings. Its largest new stake was Merit Medical Systems: 76,000 shares worth $6.36M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $12.1M trimmed.

  • Sectoral Asset Management's largest Q2 2023 buy was Merit Medical Systems: 76,000 shares worth $6.36M.
  • Sectoral Asset Management added most to Privia Health in Q2 2023, an estimated $5.98M increase.
  • Sectoral Asset Management's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $12.1M.
  • Sectoral Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $11.6M.
  • Sectoral Asset Management's ten largest holdings make up 22% of its $600M portfolio in Q2 2023.
  • Sectoral Asset Management opened 15 new positions and closed 12 in Q2 2023.
  • Sectoral Asset Management's portfolio value rose 15% quarter-over-quarter to $600M.

Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.